Abstract
An important task during the current Covid-19 pandemic is to predict the remainder of the epidemic, both without preventive measures and with. In the current paper we address this question using a simple estimation-prediction method. The input is the observed initial doubling time and a known value of R0. The simple General epidemic model is then fitted, and time calibration to calendar time is done using the observed number of case fatalities, together with estimates of the time between infection to death and the infection fatality risk. Finally, predictions are made assuming no change of behaviour, as well as for the situation where preventive measures are put in place at one specific time-point. The overall effect of the preventive measures is assumed to be known, or else estimated from the observed increased doubling time after preventive measures are put in place. The predictions are highly sensitive to the doubling times without and with preventive measures, sensitive to R0, but less sensitive to the estimates used for time-calibration: observed number of case fatalities, typical time between infection and death, and the infection fatality risk. The method is applied to the urban area of Stockholm, and predictions show that the peak of infections appear in mid-April and infections start settling in May.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Swedish Research Council
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
I have only used publicly available data
